MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing <i>PCDH10</i>

Ying Qi(State Key Laboratory of Oncogene and Related Genes), Hong Ooi(Aarhus University), Jun Wu(Shanghai Jiao Tong University), Jian Chen(State Key Laboratory of Oncogene and Related Genes), Xiaoli Zhang(State Key Laboratory of Oncogene and Related Genes), Sheng Tan(University of Science and Technology of China), Qing Yu(University of Science and Technology of China), Yuanyuan Li(Shanghai Center For Bioinformation Technology), Yani Kang(Shanghai Jiao Tong University), Hua Li(Shanghai Jiao Tong University), Z. Xiong(University of Science and Technology of China), Tao Zhu(University of Science and Technology of China), Bingya Liu(State Key Laboratory of Oncogene and Related Genes), Zhifeng Shao(Shanghai Jiao Tong University), Xiaodong Zhao(Shanghai Jiao Tong University)
Oncotarget
February 9, 2016
Cited by 132Open Access
Full Text

Abstract

// Ying Qi 1 , Hong Sain Ooi 2 , Jun Wu 3 , Jian Chen 1 , Xiaoli Zhang 1 , Sheng Tan 4 , Qing Yu 4 , Yuan-Yuan Li 5, 6 , Yani Kang 1 , Hua Li 1 , Zirui Xiong 4 , Tao Zhu 4 , Bingya Liu 1, 7 , Zhifeng Shao 1 , Xiaodong Zhao 1 1 School of Biomedical Engineering, Bio-ID Research Center, State Key Laboratory for Oncogenes and Related Genes, Shanghai Jiao Tong University, Shanghai, China 2 Department of Biomedicine, Aarhus University, Aarhus, Denmark 3 Department of Automation, Shanghai Jiao Tong University, Shanghai, China 4 Laboratory of Molecular Tumor Pathology, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China 5 Shanghai Center for Bioinformatics Technology, Shanghai, China 6 Shanghai Engineering Research Center of Pharmaceutical Translation, Shanghai, China 7 Department of Surgery, Shanghai Key Laboratory of Gastric Neoplasms, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Correspondence to: Bingya Liu, e-mail: bingyaliu@sjtu.edu.cn Xiaodong Zhao, e-mail: xiaodongzhao@sjtu.edu.cn Keywords: EZH2, RIP-seq, MALAT1, gastric cancer, transcriptional silencing Received: September 29, 2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accepted: January 23, 2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Published: February 09, 2016 ABSTRACT EZH2, the catalytic component of polycomb repressive complex 2 (PRC2), is frequently overexpressed in human cancers and contributes to tumor initiation and progression, in part through transcriptional silencing of tumor suppressor genes. A number of noncoding RNAs (ncRNAs) recruit EZH2 to specific chromatin loci, where they modulate gene expression. Here, we used RNA immunoprecipitation sequencing (RIP-seq) to profile EZH2-associated transcripts in human gastric cancer cell lines. We identified 8,256 transcripts, including both noncoding and coding transcripts, some of which were derived from cancer-related loci. In particular, we found that long noncoding RNA (lncRNA) MALAT1 binds EZH2, suppresses the tumor suppressor PCDH10 , and promotes gastric cellular migration and invasion. Our work thus provides a global view of the EZH2-associated transcriptome and offers new insight into the function of EZH2 in gastric tumorigenesis.


Related Papers

No related papers found

Powered by citation graph analysis